Method for treating alopecia by using stem cells and preparation thereof

The stem cell therapy method using CRISPR-Cas9 gene editing and nanoscale composite materials has solved the problems of limited efficacy and side effects of existing hair loss treatments, achieving highly efficient and safe hair regeneration.

CN119015204APending Publication Date: 2024-11-26SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410945666.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-15
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

Existing hair loss treatments such as medication and hair transplant surgery have limited efficacy or side effects, and hair transplant surgery is expensive and carries significant risks.

Method used

CRISPR-Cas9 gene editing technology is used to modify autologous and allogeneic mesenchymal stem cells and induced pluripotent stem cells, which are then combined with nano-scale hydroxyapatite and tricalcium phosphate composite materials. The treatment process is optimized by microneedle injection, low-intensity pulsed ultrasound, and electrical stimulation, combined with imaging examinations and biomechanical tests.

Benefits of technology

It significantly improves hair regrowth, reduces recurrence rates, enhances treatment safety and patient satisfaction, and provides a safe and effective treatment for hair loss.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015204A_ABST
    Figure CN119015204A_ABST
Patent Text Reader

Abstract

The invention discloses a method for treating alopecia by using stem cells and a preparation thereof, the source diversity of the stem cells and the application range of treatment are increased through mesenchymal stem cells and induced pluripotent stem cells from autologous and allogenic sources, so that the success rate and safety of treatment are improved, and by carrying out in-vitro amplification in a specific culture medium, the alopecia treatment effect is improved. According to the present invention, the stem cells are used as the raw material, the growth factor, the extracellular matrix component and the small molecule compound are added to significantly improve the proliferation and differentiation ability of the stem cells, and the stem cells are modified by using the CRISPR-Cas9 gene editing technology to enhance the regeneration ability and the stress resistance of the stem cells so as to significantly improve the treatment effect; the modified stem cells are compounded with a composite material containing nano-scale hydroxyapatite and tricalcium phosphate, so that the biocompatibility and function exertion of the stem cells are enhanced, and the safety and effectiveness of treatment are further improved by introducing antibacterial components, antioxidant components and angiogenesis promoting components.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine, and more particularly to a method for treating hair loss using stem cells and a preparation thereof. Background Art

[0002] Hair loss is a common clinical problem that affects the quality of life of millions of people worldwide. There are many types of hair loss, including androgenic alopecia (AGA), alopecia areata, scarring alopecia and hair loss caused by other reasons. Androgenic alopecia is the most common type, and its etiology is complex, mainly related to genetics, hormone levels and environmental factors. Hair loss not only affects appearance, but may also cause psychological problems such as anxiety and depression.

[0003] In recent years, stem cell therapy, as an emerging biological treatment method, has shown great potential. Stem cells have the ability of self-renewal and multidirectional differentiation, and can differentiate into multiple cell types under certain conditions. In particular, mesenchymal stem cells (MSCs) and induced pluripotent stem cells (iPSCs) are widely used in the fields of regenerative medicine and tissue engineering, bringing new hope to the treatment of hair loss.

[0004] Currently, the main methods for treating hair loss include medication, hair transplant surgery, laser therapy, and other physical therapy methods. Common drugs such as minoxidil and finasteride can slow down the process of hair loss or promote hair regeneration to a certain extent, but they have limited efficacy and side effects. Although hair transplant surgery can provide a more lasting effect, it is expensive and the risks of surgery cannot be ignored.

[0005] Therefore, in view of the above technical problems, it is necessary to provide a method and preparation for treating hair loss with stem cells. Summary of the invention

[0006] The purpose of the present invention is to provide a method and preparation for treating hair loss with stem cells to solve the above problems.

[0007] In order to achieve the above purpose, the technical solution provided by an embodiment of the present invention is as follows:

[0008] A method for treating hair loss with stem cells and a preparation thereof, comprising the following steps:

[0009] S1. Obtain mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources;

[0010] S2, amplifying the obtained stem cells in vitro in a specific culture medium to obtain a sufficient amount of stem cells;

[0011] S3, modifying stem cells using the CRISPR-Cas9 gene editing tool;

[0012] S4, compounding the modified stem cells with appropriate biomaterials to form a stem cell-biomaterial complex;

[0013] S5, injecting and implanting the stem cell-biomaterial complex into the patient's hair loss area through microneedles;

[0014] S6, assist with low-intensity pulsed ultrasound and electrical stimulation;

[0015] S7, postoperative care and evaluation and optimization of treatment;

[0016] Through systematic steps, from stem cell acquisition, in vitro expansion, gene editing, composite material preparation, precision injection to adjuvant treatment and postoperative care, the regenerative ability and anti-inflammatory function of stem cells are enhanced through CRISPR-Cas9 gene editing technology. Combined with advanced biomaterials and adjuvant therapies, it can significantly improve hair regeneration effects, reduce recurrence rates, and enhance patients' treatment experience and satisfaction.

[0017] As a further improvement of the present invention, the biomaterial in step S4 is a composite material containing nano-hydroxyapatite and tricalcium phosphate. The composite material of nano-hydroxyapatite and tricalcium phosphate can provide excellent biocompatibility and bioactivity, help stem cells to adhere to and survive in the hair loss area, promote hair follicle regeneration and scalp repair, and thus improve the efficiency and effectiveness of hair loss treatment.

[0018] As a further improvement of the present invention, antibacterial components, antioxidant components and pro-angiogenic components are introduced into the biomaterial. By introducing antibacterial, antioxidant and pro-angiogenic components, it is possible to effectively prevent infection, reduce oxidative stress damage to cells, promote local blood circulation, further improve the survival rate of stem cells and the hair regeneration effect, and ensure the safety and long-term effect of the treatment.

[0019] As a further improvement of the present invention, growth factors, extracellular matrix components and small molecule compounds are added to the culture medium in step S2. Adding growth factors, extracellular matrix components and small molecule compounds to the culture medium can accelerate the proliferation and differentiation of stem cells, improve their biological activity and therapeutic effects, and ensure that sufficient and powerful stem cells are obtained during the in vitro expansion process.

[0020] As a further improvement of the present invention, the pore size range of the stem cell-biomaterial complex in step S4 is set to 200-400 microns. Setting the pore size range of the stem cell-biomaterial complex to 200-400 microns helps to optimize cell nutrition supply and waste removal, provide a good cell growth environment, and promote the regeneration and functional recovery of hair follicle cells.

[0021] As a further improvement of the present invention, the stem cell-biomaterial complex is prepared by electrospinning, 3D printing and jet printing technology. The use of electrospinning, 3D printing and jet printing technology to prepare the stem cell-biomaterial complex can accurately control the structure and morphology of the material, ensure that the stem cells are evenly distributed and tightly combined, improve the stability and functionality of the complex, and enhance the therapeutic effect.

[0022] As a further improvement of the present invention, the postoperative care and evaluation in step S7 is performed by performing imaging examinations and biomechanical tests to evaluate the hair regeneration effect. By performing imaging examinations and biomechanical tests, the treatment effect can be monitored in real time, problems can be discovered and adjusted in time, and the quality and effect of hair regeneration can be ensured.

[0023] As a further improvement of the present invention, the optimized treatment in step S7 includes drug treatment and rehabilitation training, and utilizes a variety of treatment methods to enhance the overall treatment effect, shorten the recovery time, and improve the patient's satisfaction.

[0024] As a further improvement of the present invention, the gene editing in step S3 is performed through gene sequencing and analysis, and personalized gene editing is performed through gene sequencing and analysis, which can accurately treat the specific conditions of different patients, maximize the treatment effect, and reduce side effects and complications.

[0025] A stem cell preparation for treating hair loss, including mesenchymal stem cells and induced pluripotent stem cells modified by the CRISPR-Cas9 gene editing tool and a composite material containing nano-hydroxyapatite and tricalcium phosphate, can significantly improve the hair regeneration effect and provide a safe, efficient and feasible method for treating hair loss.

[0026] Compared with the prior art, the advantages of the present invention are:

[0027] (1) This approach increases the diversity of stem cell sources and the scope of therapeutic application by using autologous and allogeneic mesenchymal stem cells and induced pluripotent stem cells, thereby improving the success rate and safety of treatment. By amplifying the cells in vitro in a specific culture medium and adding growth factors, extracellular matrix components and small molecule compounds, the proliferation and differentiation capacity of stem cells is significantly enhanced, ensuring sufficient high-quality stem cells for treatment.

[0028] (2) This approach uses CRISPR-Cas9 gene editing technology to modify stem cells, precisely improve the function of stem cells, and enhance their regenerative ability and ability to resist adversity, thereby significantly improving the therapeutic effect. The modified stem cells are combined with a composite material containing nano-hydroxyapatite and tricalcium phosphate, which not only enhances the biocompatibility and functionality of the stem cells, but also further improves the safety and effectiveness of the treatment by introducing antibacterial ingredients, antioxidant ingredients, and pro-angiogenic ingredients.

[0029] (3) This program uses microneedle injection and implantation technology to precisely deliver stem cell-biomaterial complexes to the patient's hair loss area, ensuring that the stem cells can function effectively. Auxiliary treatment methods such as low-intensity pulsed ultrasound and electrical stimulation further promote the activity and growth of stem cells, significantly improving the overall treatment effect. Postoperatively, real-time evaluation and adjustment are performed through imaging examinations and biomechanical tests, combined with drug treatment and rehabilitation training to ensure the quality and stability of hair regeneration. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 It is a schematic diagram of the method steps of the present invention. DETAILED DESCRIPTION

[0031] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention; it is obvious that the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention without making creative work are within the scope of protection of the present invention.

[0032] Embodiment 1:

[0033] See also Figure 1 , a method for treating hair loss with stem cells and a preparation thereof, comprising the following steps:

[0034] S1. Obtain mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources;

[0035] S2, amplifying the obtained stem cells in vitro in a specific culture medium to obtain a sufficient amount of stem cells;

[0036] S3, modifying stem cells using the CRISPR-Cas9 gene editing tool;

[0037] S4, compounding the modified stem cells with appropriate biomaterials to form a stem cell-biomaterial complex;

[0038] S5, injecting and implanting the stem cell-biomaterial complex into the patient's hair loss area through microneedles;

[0039] S6, assist with low-intensity pulsed ultrasound and electrical stimulation for adjuvant treatment;

[0040] S7, postoperative care and evaluation and optimization of treatment;

[0041] Autologous stem cells are mainly extracted from the patient's own adipose tissue, bone marrow or peripheral blood, allogeneic stem cells can be extracted from healthy donors, and induced pluripotent stem cells are obtained from adult cells through reprogramming technology; the culture medium usually contains necessary growth factors and nutrients to promote cell proliferation and maintain their pluripotency; the purpose of gene editing is to enhance the ability of stem cells to secrete factors that promote hair regeneration and improve their anti-inflammatory immunomodulatory function to ensure that stem cells have stronger regeneration and repair capabilities; the selected biomaterials should have good biocompatibility and degradability. Commonly used materials include nano-hydroxyapatite and tricalcium phosphate. The biological activity and cell adhesion properties of the materials can be improved through plasma treatment and surface functionalization treatment; the stem cell-biomaterial complex is injected through microneedles or directly implanted into the patient's hair loss area to ensure that the stem cells reach the target area accurately and reduce trauma and side effects; low-intensity pulsed ultrasound and electrical stimulation can increase the activity and proliferation of cells, promote blood circulation and nutrient delivery, and thus enhance the therapeutic effect.

[0042] The biomaterial in step S4 is a composite material containing nano-hydroxyapatite and tricalcium phosphate. By adopting the composite material of nano-hydroxyapatite and tricalcium phosphate, it can provide excellent biocompatibility and bioactivity, help stem cells to adhere to and survive in the hair loss area, promote hair follicle regeneration and scalp repair, and thus improve the efficiency and effectiveness of hair loss treatment.

[0043] Introducing antibacterial, antioxidant and angiogenic components into biomaterials can effectively prevent infection, reduce oxidative stress damage to cells, promote local blood circulation, further improve the survival rate of stem cells and hair regeneration effect, and ensure the safety and long-term effect of treatment.

[0044] In step S2, growth factors, extracellular matrix components and small molecule compounds are added to the culture medium. By adding growth factors, extracellular matrix components and small molecule compounds to the culture medium, the proliferation and differentiation of stem cells can be accelerated, their biological activity and therapeutic effect can be improved, and sufficient and powerful stem cells can be obtained during the in vitro expansion process.

[0045] In step S4, the pore size range of the stem cell-biomaterial complex is set to 200-400 microns. By setting the pore size range of the stem cell-biomaterial complex to 200-400 microns, it helps to optimize cell nutrition supply and waste removal, provide a good cell growth environment, and promote the regeneration and functional recovery of hair follicle cells.

[0046] The stem cell-biomaterial complex is prepared by electrospinning, 3D printing and jet printing technology. By using electrospinning, 3D printing and jet printing technology to prepare the stem cell-biomaterial complex, the structure and morphology of the material can be precisely controlled to ensure that the stem cells are evenly distributed and tightly combined, thereby improving the stability and functionality of the complex and enhancing the therapeutic effect.

[0047] In step S7, postoperative care and evaluation are performed by performing imaging examinations and biomechanical tests to evaluate the hair regeneration effect. By performing imaging examinations and biomechanical tests, the treatment effect can be monitored in real time, problems can be discovered and adjusted in time, and the quality and effect of hair regeneration can be ensured.

[0048] The optimized treatment in step S7 includes drug therapy and rehabilitation training. Through drug therapy and rehabilitation training, a variety of treatment methods can be comprehensively utilized to enhance the overall treatment effect, shorten the recovery time, and improve patient satisfaction.

[0049] In step S3, gene editing is performed through gene sequencing and analysis. Personalized gene editing can be performed through gene sequencing and analysis, which can provide precise treatment for the specific conditions of different patients, maximize the treatment effect, and reduce side effects and complications.

[0050] A stem cell preparation for treating hair loss, comprising mesenchymal stem cells and induced pluripotent stem cells modified by the CRISPR-Cas9 gene editing tool and a composite material containing nano-hydroxyapatite and tricalcium phosphate. The composite material can significantly improve the hair regeneration effect by using the mesenchymal stem cells and induced pluripotent stem cells modified by the CRISPR-Cas9 gene editing tool and the composite material containing nano-hydroxyapatite and tricalcium phosphate, thus providing a safe, efficient and feasible method for treating hair loss.

[0051] It can be seen from the above technical solutions that the present invention has the following beneficial effects:

[0052] This program combines mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources, optimizes and amplifies them in a specific culture medium, uses CRISPR-Cas9 gene editing technology to accurately enhance stem cell function, and then combines them with composite materials containing nano-hydroxyapatite and tricalcium phosphate to enhance biocompatibility and regeneration effects. Advanced microneedle injection and implantation technology ensure that the stem cell-biomaterial complex is accurately delivered to the hair loss area. At the same time, low-intensity pulsed ultrasound and electrical stimulation are used as auxiliary treatments to significantly improve the efficacy. After surgery, real-time evaluation and adjustment are carried out through imaging examinations and biomechanical tests, combined with drug treatment and rehabilitation training to ensure the quality and stability of hair regeneration.

[0053] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

[0054] In addition, it should be understood that although the present specification is described according to embodiments, not every embodiment contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that those skilled in the art can understand.

Claims

1. A method for treating hair loss using stem cells, characterized in that: The following steps are involved: S1. Obtain mesenchymal stem cells and induced pluripotent stem cells from autologous and allogeneic sources; S2, amplifying the obtained stem cells in vitro in a specific culture medium to obtain a sufficient amount of stem cells; S3, modifying stem cells using the CRISPR-Cas9 gene editing tool; S4, compounding the modified stem cells with appropriate biomaterials to form a stem cell-biomaterial complex; S5, injecting and implanting the stem cell-biomaterial complex into the patient's hair loss area through microneedles; S6, assist with low-intensity pulsed ultrasound and electrical stimulation; S7. Postoperative care and evaluation and optimization of treatment.

2. A method for treating hair loss with stem cells according to claim 1, characterized in that: The biomaterial in step S4 is a composite material containing nano-sized hydroxyapatite and tricalcium phosphate.

3. The method for treating hair loss with stem cells according to claim 1, characterized in that: Antibacterial components, antioxidant components and angiogenesis-promoting components are introduced into the biomaterial.

4. The method for treating hair loss with stem cells according to claim 1, characterized in that: In step S2, growth factors, extracellular matrix components and small molecule compounds are added to the culture medium.

5. The method for treating hair loss with stem cells according to claim 1, characterized in that: In step S4, the pore size range of the stem cell-biomaterial complex is set to 200-400 microns.

6. The method for treating hair loss with stem cells according to claim 1, characterized in that: The stem cell-biomaterial complex is prepared by electrospinning, 3D printing and jet printing technology.

7. The method for treating hair loss with stem cells according to claim 1, characterized in that: In step S7, postoperative care and evaluation are performed by performing imaging examinations and biomechanical tests to evaluate the hair regeneration effect.

8. The method for treating hair loss with stem cells according to claim 1, characterized in that: The optimized treatment in step S7 includes drug therapy and rehabilitation training.

9. The method for treating hair loss with stem cells according to claim 1, characterized in that: The gene editing in step S3 is performed through gene sequencing and analysis.

10. A preparation for treating hair loss using stem cells, characterized in that: These include mesenchymal stem cells and induced pluripotent stem cells modified with the CRISPR-Cas9 gene editing tool, and composite materials containing nanoscale hydroxyapatite and tricalcium phosphate.

Citation Information

Patent Citations

  • Stem cell preparation for treating alopecia seborrhoeica

    CN113332313A

  • Stem cell compound for improving alopecia

    CN115700117A

  • Preparation containing stem cell exosome extract and application of preparation to hair growth or skin regeneration and repair

    CN115944653A

  • Culture medium for promoting and inducing mesenchymal stem cells to differentiate into dermal papilla cells and induction method

    CN117551600A